Active	Status	Sponsor type	Region	Phase	Filter
17 Active 56 Inactive 73 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

17 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Tack, Jan
NCT03024879: The Effect of Motilin on the Frequency and Amount of Food Intake	Enrolling by invitation	4	15	NA	Erythromycin, Saline	Universitaire Ziekenhuizen KU Leuven	Healthy, Obesity	03/25	03/25
NaloxegolHRM, NCT05770960: Colonic Motor Patterns in Healthy Volunteers	Completed	4	15	Europe	Naloxegol, Movantik, Moventig, codeine phosphate, Bronchodine, Placebo, Siripus simplex syrup	Universitaire Ziekenhuizen KU Leuven	Opioid-Induced Constipation	05/19	05/19
NCT05071781: Effect of CRH on Duodenal Markers and Gastric Sensorimotor Function	Completed	4	20	Europe	Corticotropin-release hormone	Universitaire Ziekenhuizen KU Leuven	GI Motility Disorder	12/22	12/22
NCT05629325: Buspirone for Weak or Absent Esophageal Peristalsis	Recruiting	4	25	Europe	Buspirone Hydrochloride 10 MG, Buspiron, Placebo	Universitaire Ziekenhuizen KU Leuven	Dysphagia, Esophageal	09/24	09/24
PEPPER, NCT05629143: Primary carE PPi dEprescRibing Trial	Recruiting	4	724	Europe	de-prescription of PPI via intermittent scheme, de-prescription of PPI via on-demand scheme, Alginate	Universitaire Ziekenhuizen KU Leuven	Heartburn, Dyspepsia, Reflux	09/25	09/25
MOVE-IT, NCT05621811 / 2021-002254-86: Different Doses of Naronapride vs. Placebo in Gastroparesis	Recruiting	2	320	Europe, US	Naronapride, Placebo	Dr. Falk Pharma GmbH, Dr. Falk Pharma GmbH	Gastroparesis	01/25	04/25
PASIPHY, NCT05928390: Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia	Recruiting	2	72	Europe, US	Pasireotide Diaspartate, Pasireotide	RECORDATI GROUP	Post-Bariatric Hypoglycemia	04/25	04/26
CLE-EoE, NCT05695456: Targeted Elimination Diet in EoE Patients Following Identification of Trigger Nutrients Using Confocal Laser Endomicroscopy	Recruiting	1/2	25	Europe	personalized exclusion diet based on CLE, empiric exclusion diet	Universitaire Ziekenhuizen KU Leuven	Eosinophilic Esophagitis	12/24	12/24
NCT04873011: Effect of Quinine Hydrochloride in Overweight Population on Food Intake, Hunger and Gut Peptide Release	Recruiting	1	40	Europe	Quinine Hydrochloride, Placebo	Universitaire Ziekenhuizen KU Leuven	Obesity	10/25	10/25
NCT05651386: The Six Food Elimination in Postprandial Distress Syndrome	Recruiting	N/A	15	Europe	Diet	Universitaire Ziekenhuizen KU Leuven	Functional Dyspepsia	01/25	01/25
ICOF, NCT06488534: Intracolonic FODMAP Infusion in Healthy Volunteers	Recruiting	N/A	15	Europe	Fermentable Oligo-, Di- Monosaccharides And Polyols (FODMAPs)	Universitaire Ziekenhuizen KU Leuven, University of Auckland, New Zealand	Irritable Bowel Syndrome	09/24	09/24
OCARINA, NCT05740631 / 2020-004180-13: The Effect of Obeticholic Acid in Healthy Volunteers	Recruiting	N/A	12	Europe	Ocaliva, obeticholic acid, Placebo, Placebo Oral Tablet (Starch)	Universitaire Ziekenhuizen KU Leuven, Intercept Pharmaceuticals	Healthy	07/23	07/23
NCT05877781: PEA in Functional Dyspepsia	Recruiting	N/A	100	Europe	Palmitoylethanolamide	Universitaire Ziekenhuizen KU Leuven	Dyspepsia and Other Specified Disorders of Function of Stomach	01/25	03/25
FFDU, NCT05832528: Low FODMAP Diet in FD (PDS)	Recruiting	N/A	30	Europe	Low-FODMAP diet	Universitaire Ziekenhuizen KU Leuven	Functional Gastrointestinal Disorders	01/25	02/25
EDDI, NCT05808036: Efficacy of the DOMINO Diet App in IBS	Recruiting	N/A	100	Europe	Dietary intervention: DOMINO app, Dietary intervention: low FODMAP diet	Universitaire Ziekenhuizen KU Leuven	Irritable Bowel Syndrome	11/24	11/24
NCT05780749: A 14-week Pilot Prospective Clinical Trial With BiOkuris Product in Patients With Irritable Bowel Syndrome	Recruiting	N/A	130	Europe	DDI-IBS-001, DDDI-IBS-001 placebo	Biokuris s.a.	Irritable Bowel Syndrome	12/24	12/24
Beeckmans, Dorien
SOPRANO-CD, NCT05169593: Prevention of Postoperative Endoscopic Recurrence with Endoscopy-driven Versus Systematic Biological Therapy	Recruiting	4	292	Europe	Biological Drug, Risankizumab, Vedolizumab, Ustekinumab, Infliximab, Adalimumab	Universitaire Ziekenhuizen KU Leuven	Crohn Disease	10/27	10/30